These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32631869)

  • 21. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
    Estancial CS; Rodrigues RL; De Nucci G; Antunes E; Mónica FZ
    BJU Int; 2015 Oct; 116(4):657-64. PubMed ID: 25715977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct sGC activation bypasses NO scavenging reactions of intravascular free oxy-hemoglobin and limits vasoconstriction.
    Raat NJ; Tabima DM; Specht PA; Tejero J; Champion HC; Kim-Shapiro DB; Baust J; Mik EG; Hildesheim M; Stasch JP; Becker EM; Truebel H; Gladwin MT
    Antioxid Redox Signal; 2013 Dec; 19(18):2232-43. PubMed ID: 23697678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble Guanylate Cyclase Modulators, BAY 41-2272 and BAY 60-2770, Inhibit Human and Rabbit Prostate Contractility.
    Calmasini FB; Alexandre EC; Silva FH; De Nucci G; Antunes E; D'Ancona CA; Mónica FZ
    Urology; 2016 Aug; 94():312.e9-312.e15. PubMed ID: 27131967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine 135 of the β
    Rühle A; Elgert C; Hahn MG; Sandner P; Behrends S
    Eur J Pharmacol; 2020 Aug; 881():173203. PubMed ID: 32446711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma.
    Ghosh A; Koziol-White CJ; Asosingh K; Cheng G; Ruple L; Groneberg D; Friebe A; Comhair SA; Stasch JP; Panettieri RA; Aronica MA; Erzurum SC; Stuehr DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2355-62. PubMed ID: 27071111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capillary hemodynamics and contracting skeletal muscle oxygen pressures in male rats with heart failure: Impact of soluble guanylyl cyclase activator.
    Weber RE; Schulze KM; Colburn TD; Horn AG; Hageman KS; Ade CJ; Hall SE; Sandner P; Musch TI; Poole DC
    Nitric Oxide; 2022 Feb; 119():1-8. PubMed ID: 34871799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A thalidomide-hydroxyurea hybrid increases HbF production in sickle cell mice and reduces the release of proinflammatory cytokines in cultured monocytes.
    Lanaro C; Franco-Penteado CF; Silva FH; Fertrin KY; Dos Santos JL; Wade M; Yerigenahally S; de Melo TR; Chin CM; Kutlar A; Meiler SE; Costa FF
    Exp Hematol; 2018 Feb; 58():35-38. PubMed ID: 29108926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyurea with AKT2 inhibition decreases vaso-occlusive events in sickle cell disease mice.
    Barazia A; Li J; Kim K; Shabrani N; Cho J
    Blood; 2015 Nov; 126(22):2511-7. PubMed ID: 26265698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells.
    Cokic VP; Andric SA; Stojilkovic SS; Noguchi CT; Schechter AN
    Blood; 2008 Feb; 111(3):1117-23. PubMed ID: 17993617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
    Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK
    Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronological Change of Vascular Reactivity to cGMP Generators in the Balloon-Injured Rat Carotid Artery.
    Tawa M; Shimosato T; Sakonjo H; Masuoka T; Nishio M; Ishibashi T; Okamura T
    J Vasc Res; 2019; 56(3):109-116. PubMed ID: 31085923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice.
    Leiria LO; Silva FH; Davel AP; Alexandre EC; Calixto MC; De Nucci G; Mónica FZ; Antunes E
    J Urol; 2014 Feb; 191(2):539-47. PubMed ID: 24050894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro induction of fetal hemoglobin in human erythroid progenitor cells.
    Ho JA; Pickens CV; Gamcsik MP; Colvin OM; Ware RE
    Exp Hematol; 2003 Jul; 31(7):586-91. PubMed ID: 12842703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of BAY 60-2770, a Soluble Guanylate Cyclase Activator, for Coronary Spasm in Animal Models.
    Tawa M; Nakagawa K; Ohkita M
    J Pharmacol Exp Ther; 2024 Aug; 390(3):280-287. PubMed ID: 38262743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble guanylate cyclase stimulators in pulmonary hypertension.
    Stasch JP; Evgenov OV
    Handb Exp Pharmacol; 2013; 218():279-313. PubMed ID: 24092345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase.
    Cokic VP; Smith RD; Beleslin-Cokic BB; Njoroge JM; Miller JL; Gladwin MT; Schechter AN
    J Clin Invest; 2003 Jan; 111(2):231-9. PubMed ID: 12531879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia.
    Walker AL; Steward S; Howard TA; Mortier N; Smeltzer M; Wang YD; Ware RE
    Blood; 2011 Nov; 118(20):5664-70. PubMed ID: 21921042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
    Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants.
    Wobst J; von Ameln S; Wolf B; Wierer M; Dang TA; Sager HB; Tennstedt S; Hengstenberg C; Koesling D; Friebe A; Braun SL; Erdmann J; Schunkert H; Kessler T
    Basic Res Cardiol; 2016 Jul; 111(4):51. PubMed ID: 27342234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.